Fujii Takaaki, Yajima Reina, Tatsuki Hironori, Oosone Katsuya, Kuwano Hiroyuki
Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Gunma 371-8511, Japan.
Oncol Lett. 2017 Dec;14(6):7025-7030. doi: 10.3892/ol.2017.6768. Epub 2017 Aug 18.
It has been reported that F18-fluorodeoxyglucose (FDG) uptake in the neck and supraclavicular lesions represents activated brown adipose tissue (BAT). In the present study, the association between BAT activity, detected by FDG-positron emission tomography (PET), and the clinicopathological features of patients with breast cancer was investigated. The cases of 156 consecutive patients with breast cancer who underwent FDG-PET preoperatively were analyzed. The distribution and intensity of atypical FDG uptake in the neck and/or supraclavicular region was reviewed. The intensity was graded as follows: 1, weak; 2, moderate; and 3, intense. Among the 156 patients, 70 (44.9%) exhibited grade 1 intensity, 65 (41.7%) exhibited grade 2 intensity and 21 (13.5%) exhibited grade 3 intensity. The intensity of FDG was significantly associated with human epidermal growth factor receptor 2 (HER2) expression and progesterone expression. Among the 156 patients, 6 (3.8%) had recurrent disease. Multivariate analysis revealed that showing a low grade of atypical FDG uptake was the only independent risk factor of short-term recurrence, and none of the patients with recurrent disease had atypical FDG uptake that may reflect the activation of BAT. These results indicated that the presence of BAT is associated with HER2 expression and the absence of BAT may be a prognostic factor for breast cancer.
据报道,颈部和锁骨上病变中F18-氟脱氧葡萄糖(FDG)摄取代表活化的棕色脂肪组织(BAT)。在本研究中,研究了通过FDG正电子发射断层扫描(PET)检测到的BAT活性与乳腺癌患者临床病理特征之间的关联。分析了156例术前接受FDG-PET检查的连续乳腺癌患者的病例。回顾了颈部和/或锁骨上区域非典型FDG摄取的分布和强度。强度分级如下:1级,弱;2级,中度;3级,强。在156例患者中,70例(44.9%)表现为1级强度,65例(41.7%)表现为2级强度,21例(13.5%)表现为3级强度。FDG强度与人类表皮生长因子受体2(HER2)表达和孕激素表达显著相关。在156例患者中,6例(3.8%)有复发疾病。多变量分析显示,非典型FDG摄取低分级是短期复发的唯一独立危险因素,且复发疾病患者中无一例有可反映BAT活化的非典型FDG摄取。这些结果表明,BAT的存在与HER2表达相关,而BAT的缺失可能是乳腺癌的一个预后因素。